These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9284975)

  • 1. New drug effects on bacteria, the antiplasmid effect.
    Molnár J
    Acta Microbiol Immunol Hung; 1997; 44(1):21-6. PubMed ID: 9284975
    [No Abstract]   [Full Text] [Related]  

  • 2. Facing antibiotic resistance.
    Livermore DM
    West Indian Med J; 2001 Mar; 50(1):5-7. PubMed ID: 11398288
    [No Abstract]   [Full Text] [Related]  

  • 3. Shooting the messenger of antibiotic resistance: plasmid elimination as a potential counter-evolutionary tactic.
    Amábile-Cuevas CF; Heinemann JA
    Drug Discov Today; 2004 Jun; 9(11):465-7. PubMed ID: 15149615
    [No Abstract]   [Full Text] [Related]  

  • 4. Bacterial monopolists: the bundling and dissemination of antimicrobial resistance genes in gram-positive bacteria.
    Rice LB
    Clin Infect Dis; 2000 Sep; 31(3):762-9. PubMed ID: 11017827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroquinolone resistance: mechanisms and epidemiology.
    Tillotson GS; Dorrian I; Blondeau J
    J Med Microbiol; 1997 Jun; 46(6):457-61. PubMed ID: 9379475
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characterization of plasmids which mediate resistance to multiple antibiotics in gram-negative bacteria of nosocomial origin].
    Araque M; Nieves B; Ruiz O; Dagert M
    Enferm Infecc Microbiol Clin; 1997; 15(6):299-305. PubMed ID: 9376400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fluoroquinolones].
    Lumio J
    Duodecim; 1991; 107(10):757-64. PubMed ID: 1364719
    [No Abstract]   [Full Text] [Related]  

  • 8. Appropriate antimicrobial prescribing: approaches that limit antibiotic resistance.
    Colgan R; Powers JH
    Am Fam Physician; 2001 Sep; 64(6):999-1004. PubMed ID: 11578036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isolation and characterization of bacterial strains resistant to arsenical compounds].
    Pimenov EV; Darmov IV; Pogorel'skiĭ IP; Ianov SN; Kulikov OA; Kalinichenko VB
    Mikrobiologiia; 1996; 65(2):214-8. PubMed ID: 8724754
    [No Abstract]   [Full Text] [Related]  

  • 10. Importance of integrons in the diffusion of resistance.
    Carattoli A
    Vet Res; 2001; 32(3-4):243-59. PubMed ID: 11432416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87).
    Barnard FM; Maxwell A
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1994-2000. PubMed ID: 11408214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of bacterial resistance to antimicrobial agents.
    Stratton CW
    J Med Liban; 2000; 48(4):186-98. PubMed ID: 11214188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplasmid activity of 1'-acetoxychavicol acetate from Alpinia galanga against multi-drug resistant bacteria.
    Latha C; Shriram VD; Jahagirdar SS; Dhakephalkar PK; Rojatkar SR
    J Ethnopharmacol; 2009 Jun; 123(3):522-5. PubMed ID: 19501283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infectiology during change: prospects and controversies].
    Kelm-Kahl I
    Dtsch Med Wochenschr; 1999 May; 124(18):A7. PubMed ID: 10356576
    [No Abstract]   [Full Text] [Related]  

  • 15. [Origin, evolution, and migration of drug resistance genes].
    Mindlin SZ; Petrova MA; Bass IA; Gorlenko ZhM
    Genetika; 2006 Nov; 42(11):1495-511. PubMed ID: 17163068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Distribution and diversity of conjugative plasmids among some multiple antibiotic resistant E.coli strains isolated from river waters].
    Cernat R; Lazăr V; Balotescu C; Cotar A; Coipan E; Cojocaru C
    Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):147-53. PubMed ID: 15085604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of bacterial resistance to antibiotics].
    Jovanović N; Jovanović J; Stefan-Mikić S; Kulauzov M; Aleksic-Dordević M; Cvjetković D
    Med Pregl; 2008; 61 Suppl 1():9-14. PubMed ID: 19248637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium.
    Dutta NK; Annadurai S; Mazumdar K; Dastidar SG; Kristiansen JE; Molnar J; Martins M; Amaral L
    Int J Antimicrob Agents; 2007 Sep; 30(3):242-9. PubMed ID: 17644318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new challenge to the treatment of acute lower respiratory tract bacterial infections].
    Deng W
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):515. PubMed ID: 11360500
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenomic strategies against resistance development in microbial infections.
    Ziebuhr W; Xiao K; Coulibaly B; Schwarz R; Dandekar T
    Pharmacogenomics; 2004 Jun; 5(4):361-79. PubMed ID: 15165173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.